United Kingdom - English - myHealthbox

novartis vaccines and diagnostics - neisseria meningitidis group c (strain c11) oligosaccharide, corynebacterium diphtheriae crm197 protein , adsorbed on aluminium - suspension for injection - 10micrograms, 12.5 to 25.0micrograms, 0.3 to 0.4mg al 3+ - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

United Kingdom - English - myHealthbox

novartis vaccines and diagnostics - neisseria meningitidis group c (strain c11) oligosaccharide, corynebacterium diphtheriae crm197 protein , adsorbed on aluminium - suspension for injection - 10micrograms, 12.5 to 25.0micrograms, 0.3 to 0.4mg al 3+ - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corp - meningococcal polysaccharide vaccine group a,c,y and w-135 combined (single dose) - lyophilized powder for injection sc

Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corp - meningococcal polysaccharide vaccine groups a,c,y and w-135 combined (multidose) -

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - meningococcal polysaccharide vaccine, group a, c, w135 and y - lyophilized powder for injection (sc) - 50 mcg/ 0.5ml

Philippines - English - FDA (Food And Drug Administration)

pfizer, inc. - meningococcal polysaccharide vaccine, group a, c, w135 and y - powder for injection sc

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - meningococcal polysaccharide group a,meningococcal polysaccharide group c,meningococcal polysaccharide group w135,meningococcal polysaccharide group y -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - meningococcal polysaccharide group a,meningococcal polysaccharide group c,meningococcal polysaccharide group w135,meningococcal polysaccharide group y -

Malta - English - Medicines Authority

gsk vaccines s.r.l via fiorentina i, 53100 siena,, italy - meningococcal polysaccharide, group c - suspension for injection - meningococcal polysaccharide group c 10/0.5 microgram(s)/millilitre - vaccines

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi pasteur, united states - meningococcal group a (neisseria meningitidis) polysaccharide vaccine,meningococcal group c (neisseria meningitidis) polysaccharide,meningococcal group y (neisseria meningitidis) polysaccharide,meningococcal group w (neisseria meningitidis) polysaccharide,diphtheria toxoid - solution for injection - 4,4,4,4,48 µg,